Join the ACGS

To join the ACGS you must join The British Society for Genetic Medicine, of which the ACGS is a constituent group.

A new membership portal has opened please create an account there to start your application for membership. You may also wish to see the BSGM page for more details.

Announcement: New reduced membership rate

To make the ACGS more accessible to our technologist colleagues we are pleased to announce a new band 5 and below membership rate launched at the Genetic Technologist Study Day 29th April 2016 in Manchester.

Please see the top right of this page for a downloadable flyer with more details.

Applicants should apply online via the link above and select ACGS Band 5 and below membership. Please can applicants also email a copy of their pay slip or a letter from their Head of Laboratory confirming pay band to the BSGM office

Existing members should email David Cockburn with a copy of their pay slip or letter from head of laboratory to arrange a reduction in fees from 2016/2017 only.

Announcement: membership fees for trainees

With the launch of the band 5 £20 membership rate for ACGS, it has come to our attention that some trainees (on band 6) have paid for 2016/17 membership at a £20 rate already - which was mistakenly advertised on the BSGM website.

We wish to apologise for any confusion, but there is no reduction in fees available except for those on band 5 or below. The BSGM website has now been corrected.

It has been decided that those fortunate trainees who have already processed payments at the £20 rate will not be surcharged, but they should note that they will be required to pay the full rate next year.


Related Files

    Latest News

  • ClinGen/ACGS collaboration

    posted 5th February 2018  |  0 Comments

    Association for Clinical Genomic Science (ACGS) has entered into a formal affiliation with the ClinGen Inherited Cardiomyopathy Expert Panel (CMP-EP). We will be working jointly to adapt the ACMG/AMP variant classification guidelines for genes associated with hypertrophic cardiomyopathy (HCM). This work is an extension of the ClinGen CMP-EP's recommendations for MYH7 variant classification. ClinGen and ACGS have a shared goal of developing standardised genomic variant interpretation guidelines for improved patient care. The contribution of genomic and phenotypic data from both groups, as well as collaboration in the decision-making process, represents a first step in global development, acceptance, and use of a common set of specified guidelines.

    Read more